Search research articles
Contact Us
Filters
Showing results (1-10 of 159) with videos related to
Page
of 16
Sort By:
Cancer Genetics and Cytogenetics
|
November 1, 1988
Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis
D Przepiorka
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1988
Elevated beta-2-microglobulin in Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation
D Przepiorka
Cytotherapy
|
September 15, 2009
FDA wrokshop summary: FDA-NCI workshop on tumor vaccines
D Przepiorka
Cytotherapy
|
May 25, 2002
The CDC Guidelines for Prevention of Infections: rule with reason
D Przepiorka
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 1, 1986
A single-step silver enhancement method permitting rapid diagnosis of cytomegalovirus infection in formalin-fixed, paraffin-embedded tissue sections by in situ hybridization and immunoperoxidase detection
D Przepiorka, D Myerson
American Journal of Hematology
|
August 1, 1996
When is selection bias not selection bias
D Przepiorka, E Estey
Bone Marrow Transplantation
|
October 1, 1990
Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C
D Przepiorka, R Gonzales-Chambers
Molecular Medicine Today
|
December 19, 1998
Heat shock protein--peptide complexes as immunotherapy for human cancer
D Przepiorka, P K Srivastava
Bone Marrow Transplantation
|
March 1, 1988
Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia
D Przepiorka, E D Thomas
Digestive Diseases and Sciences
|
January 1, 1993
Infectious complications of endoscopic procedures in bone marrow transplant recipients
M Kaw, D Przepiorka, G Sekas
Page
of 16
Search research articles
Search
Showing results (1-10 of 159) with videos related to
Sort By:
Page
of 16
Cancer Genetics and Cytogenetics
|
November 1, 1988
Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis
D Przepiorka
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1988
Elevated beta-2-microglobulin in Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation
D Przepiorka
Cytotherapy
|
September 15, 2009
FDA wrokshop summary: FDA-NCI workshop on tumor vaccines
D Przepiorka
Cytotherapy
|
May 25, 2002
The CDC Guidelines for Prevention of Infections: rule with reason
D Przepiorka
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 1, 1986
A single-step silver enhancement method permitting rapid diagnosis of cytomegalovirus infection in formalin-fixed, paraffin-embedded tissue sections by in situ hybridization and immunoperoxidase detection
D Przepiorka, D Myerson
American Journal of Hematology
|
August 1, 1996
When is selection bias not selection bias
D Przepiorka, E Estey
Bone Marrow Transplantation
|
October 1, 1990
Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C
D Przepiorka, R Gonzales-Chambers
Molecular Medicine Today
|
December 19, 1998
Heat shock protein--peptide complexes as immunotherapy for human cancer
D Przepiorka, P K Srivastava
Bone Marrow Transplantation
|
March 1, 1988
Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia
D Przepiorka, E D Thomas
Digestive Diseases and Sciences
|
January 1, 1993
Infectious complications of endoscopic procedures in bone marrow transplant recipients
M Kaw, D Przepiorka, G Sekas
Page
of 16